Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Category: 271(e)(1) Safe Harbor
-
A Federal Circuit panel of Judges Newman, Rader, and Prost heard oral arguments Monday in Integra LifeSciences v. Merck KGaA, No. 02-1052. An mp3 audio file of the 45-minute session is available here (be patient when downloading this; it’s a 40 mB file). The case involves the scope of the "FDA exemption" under 35 U.S.C.…
Orange Book Blog 